Načítá se...
New Drugs on the Block—Emerging Treatments for Nonalcoholic Steatohepatitis
Patients with nonalcoholic steatohepatitis (NASH) are at higher risk of progression to advanced stages of fibrosis, cirrhosis, hepatocellular carcinoma and other end-stage liver disease complications. When addressing treatment of NASH, we have limited approved options, and the mainstay of therapy is...
Uloženo v:
| Vydáno v: | J Clin Transl Hepatol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
XIA & HE Publishing Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7868699/ https://ncbi.nlm.nih.gov/pubmed/33604255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2020.00057 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|